Sun.Mar 31, 2024

article thumbnail

Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs

Drug Patent Watch

A recent study published in JAMA Health Forum sheds light on the impact of biosimilar competition on patient out-of-pocket (OOP) costs for biologic drugs in the United States.

article thumbnail

2024 KDIGO Guidelines: The MOST Important Medication Recommendations

Med Ed 101

The Kidney Disease: Improving Global Outcomes (KDIGO) organization has released an updated April 2024 clinical practice guideline for the evaluation and management of Chronic Kidney Disease (CKD). The new 2024 KDIGO guidelines include 6 chapters dedicated to the evaluation of CKD, risk assessment in people with CKD, management to delay CKD progression and manage its […] The post 2024 KDIGO Guidelines: The MOST Important Medication Recommendations appeared first on Med Ed 101.

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Active cooperation among APAC pharma companies gaining traction: GlobalData

Express Pharma

In the dynamic landscape of the pharma industry, collaboration often serves as the key to innovation and expanding market presence. In recent years, the Asia-Pacific (APAC) market has emerged as a hub for pharmaceutical development and investment, attracting attention from both local and global players. While cooperation between APAC-based pharmaceutical companies and their global counterparts has been on the rise, active cooperation among pharma companies within the APAC region is gaining tract

article thumbnail

New patent expiration for The Medicines drug IONSYS

Drug Patent Watch

Annual Drug Patent Expirations for IONSYS Ionsys is a drug marketed by The Medicines Co and is included in one NDA. There are eight patents protecting this drug.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Jubilant Ingrevia commissions new facility for Diketene and derivatives

Express Pharma

Jubilant Ingrevia has commissioned a new facility at its manufacturing site for Diketene derivatives at Gajraula, Uttar Pradesh. The company presently has over 134 products and solutions commercialised. It has developed proficiency across ~35 key chemistry and technology platforms across its businesses: Specialty, Nutrition and Chemical Intermediates.

79
article thumbnail

DrugGPT: new AI tool could help doctors prescribe medicine in England

The Guardian - Pharmaceutical Industry

New tool may offer prescription ‘safety net’ and reduce the 237m medication errors made each year in England Drugs are a cornerstone of medicine, but sometimes doctors make mistakes when prescribing them and patients don’t take them properly. A new AI tool developed at Oxford University aims to tackle both those problems. DrugGPT offers a safety net for clinicians when they prescribe medicines and gives them information that may help their patients better understand why and how to take them.

73

More Trending

article thumbnail

Tinnitus

RX Note

Introduction Tinnitus is a perception of sound in proximity to head in the absence of an external source. It can be perceived as being within one or both ears, within or around the head, or as an outside distant noise. The sound is often a buzzing, ringing or hissing , although it can sound like other noises. It may be continuous or intermittent (occasional), can be pulsing or steady, and can range in severity from a soft buzz to a loud ring.

article thumbnail

Episode 909: Is this a better metric for antibiotic stewardship?

Pharmacy Joe

In this episode, I’ll discuss a novel metric for antibiotic stewardship. Episode 909: Is this a better metric for antibiotic stewardship? Subscribe on iTunes , Android , or Stitcher Days of Therapy (DOT) is probably the most common metric to track antimicrobial stewardship efforts related to antibiotic consumption. DOT is not a perfect metric as it is calculated by calendar day regardless of the number of doses given, however, it is easily calculated which probably contributes to its popul

article thumbnail

10 ChatGPT Hacks That Can Transform Your Pharmacy Operations

pharmacy mentor

When it comes to pharmacy management, harnessing the power of artificial intelligence can significantly streamline operations, enhance patient care, and improve overall efficiency. Some pharmacies have already begun using AI to handle a wide variety of tasks. ChatGPT being the most popular tool right now. However, the vast majority of pharmacies (and we’re talking about 90% or so) are still in the dark about it, and are not using it.

article thumbnail

New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide

Drug Patent Watch

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Navigating Paxlovid Interactions With Anticoagulants

Pharmacy Times

Interactions between nirmatrelvir/ritonavir and direct oral anticoagulants is complicated, and a point of contrasting views between the US and EU medical communities.

40
article thumbnail

Which pharmaceutical companies have the most SPCs in Ireland?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland.